Roadmap 2.0 information system for Cancer

Phase-Based Progress Estimates
University of Michigan Rogel Cancer Center, Ann Arbor, MICancer+1 MoreRoadmap 2.0 information system - Behavioral
Any Age
All Sexes
What conditions do you have?

Study Summary

This trial will study how well a mobile app (Roadmap 2.0) and Fitbit help caregivers of cancer patients. The goal is to see if using the app is feasible and acceptable.

Eligible Conditions
  • Quality of Life
  • Cancer

Treatment Effectiveness

Study Objectives

2 Primary · 1 Secondary · Reporting Duration: At time of enrollment

At time of enrollment
Enrollment rate
Day 120
Roadmap 2.0 login rate
Survey completion rate

Trial Safety

Trial Design

1 Treatment Group

Roadmap 2.0 + Fitbit Charge 3
1 of 1

Experimental Treatment

100 Total Participants · 1 Treatment Group

Primary Treatment: Roadmap 2.0 information system · No Placebo Group · N/A

Roadmap 2.0 + Fitbit Charge 3Experimental Group · 3 Interventions: Survey administration, Wearable activity sensor, Roadmap 2.0 information system · Intervention Types: Other, Other, Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: at time of enrollment

Who is running the clinical trial?

University of Michigan Rogel Cancer CenterLead Sponsor
270 Previous Clinical Trials
18,055 Total Patients Enrolled
Sung Won Choi, MD, MSPrincipal InvestigatorUniversity of Michigan Rogel Cancer Center
4 Previous Clinical Trials
3,295 Total Patients Enrolled

Eligibility Criteria

Age Any Age · All Participants · 9 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you: